Table II.

Toxicity - Evaluable Patients Only (N=17)

Maximum grade	N (%)
Nausea
0 (none)	2 (12%)
1	11 (65%)
2	2 (12%)
3	2 (12%)
Vomiting
0 (none)	14 (82%)
1	1 (6%)
2	2 (12%)
Dyspnea
0 (none)	3 (18%)
1	9 (53%)
2	1 (6%)
3	4 (24%)
Fever w/o infection
0 (none)	5 (29%)
1	5 (29%)
2	5 (29%)
3	2 (12%)
Chills
0 (none)	3 (18%)
1	10 (59%)
2	4 (24%)
Myalgia
0 (none)	4 (24%)
1	1 (6%)
2	6 (35%)
3	5 (29%)
4	1 (6%)
Sweats
0 (none)	1 (6%)
1	9 (53%)
2	6 (35%)
3	1 (6%)
Malaise
0 (none)	0
1	1 (6%)
2	7 (41%)
3	7 (41%)
4	2 (12%)
Edema
0 (none)	7 (41%)
1	7 41%)
2	3 (18%)
Cough
0 (none)	9 (53%)
1	5 (29%)
2	2 (12%)
3	1 (6%)
Pain
0 (none)	15 (88%)
1	1 (6%)